SBIR/STTR Research Award
A Force-controlled Probe Based Platform for Single-Cell Biomolecular Delivery
Award amount
$999,998Program and phase
SBIR · Phase IIAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INFINITESIMAL, LLC
- Proposal award date
- 2015-05-01
- Contract end date
- 2018-04-30
- UEI
- Not reported
- Solicitation number
- PA13-235
- Topic code
- 100
Research abstract
DESCRIPTION provided by applicant This proposed Phase II project will lead to a commercial product capable of transfecting individual target cells This new biotool uses a patented microfabricated chip called a nanofountain probe NFP to deliver molecules into live individual target cells by single cell electroporation which induces temporary nanopores in the cell membrane via the application of an electrical field that is localized at the tip of a microfludic cantilever on the NFP chip This novel transfection technique is called nanofountain probe electroporation NFP E and it has shown incredible promise for translation into a novel commercial biotool Existing techniques for single cell transfection such as microinjection and electroporation by micropipette require extensive operator training are highly user dependent and labor intensive and routinely damage cells from excessive mechanical force on the cell membrane The NFP cantilever reduces the mechanical stress on the cell membrane and can be tailored during fabrication The long term objective of this project is to develop the first sinle cell transfection system that is easy to use gentle on cells and automated to offer relatively high throughput and eliminate user dependent variability The specific aims for this proposal are the following to optimize the design of product components for plug and play assembly and easy solution loading and recovery to develop software for image processing and analysis to simplify NFP Electroporation by automating the process of locating target cells detecting contact of the NPF tip with a cell membrane and applying the electric field and to perform three key transfection experiments to demonstrate the potential of the NFP E in Randamp D to establish experimental protocols collect statistics of efficiency viability verify specifications
efficiency viability throughput and refine the image recognition software for a number of cell
lines and primary cells Accomplishing these aims will produce a product that could enable new capabilities for single cell research and therapeutics including cell reprogramming differentiation cell cell signaling gene expression and protein interaction cell to cell variability drug discovery personalized drug response diagnostics and personalized medicine PUBLIC HEALTH RELEVANCE This project will lead to the development of the nanofountain probe electroporation system NFP E System the first commercial product capable of delivering molecules into individual target cells in an automated easy to use and gentle method This new biotool for single cell research and development will offer high throughput and eliminate user dependent variability to enable new capabilities for biological research and therapeutics particularly for drug discovery personalized drug response diagnostics and personalized medicine based on stem cells
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing